Patent Library
Patent Library
In accordance with Section 287(a) of Title 35 of the United States Code, the following identifies Pharvaris’ rights in U.S. patents associated with the indicated clinical candidate. The absence of a U.S. patent number from this list does not constitute a waiver of Pharvaris’ patent, trademark, or other intellectual property rights.
Please find the Compound or Pipeline Asset and associated United States Patents below.
Deucrictibant
Oral bradykinin B2 receptor antagonist.
Oral bradykinin B2 receptor antagonist.
Patented under and/or used under U.S. Patent Numbers:
- U.S. Patent No. 10,836,748 B2
- U.S. Patent No. 11,261,173 B2
- U.S. Patent No. 11,820,756 B2
- U.S. Patent No. 12,629,363 B2